Monday, February 3, 2020

Alphabet Q4 Profit Rises; Revenue Up 17%

Alphabet Inc. (GOOG, GOOGL) reported fourth-quarter earnings per share of $15.35 compared to $12.77, a year ago. On average, 35 analysts polled by Thomson Reuters expected the company to report profit per share of $12.59, for the quarter. Analysts' estimates typically exclude special items. Net income increased to $10.67 billion from $8.95 billion, previous year.

from RTT - Earnings https://ift.tt/36Vabw4
via IFTTT
Read More »

Compugen (CGEN) Hits A High - A Transformative Year Gone, A Busy Year Ahead

Shares of Compugen Ltd. (CGEN) hit a new 52-week high of $7.62 in early trading today and are currently at $7.53.

from RTT - Biotech https://ift.tt/2Sd38Ka
via IFTTT
Read More »

Bargain Hunting May Contribute To Initial Strength On Wall Street

The major U.S. index futures are currently pointing to a higher opening on Monday following the sell-off seen in the previous session.

from RTT - Market Analysis https://ift.tt/2uisf66
via IFTTT
Read More »

United Therapeutics' Small Cell Lung Cancer Study Primary Endpoint Not Meet

United Therapeutics Corp. (UTHR) announced Monday topline results from the phase 2/3 DISTINCT clinical study evaluating Unituxin (dinutuximab) Injection added to irinotecan compared to irinotecan or topotecan alone in patients with relapsed or refractory small cell lung cancer (SCLC).

from RTT - Biotech https://ift.tt/394F0QI
via IFTTT
Read More »

Itamar Medical In Wake-up Mode?

Shares of Itamar Medical Ltd. (ITMR), which closed at an all-time high of $15.73 on Friday, have gained an impressive 22% so far this year.

from RTT - Biotech https://ift.tt/36OJZU9
via IFTTT
Read More »

FDA Approves First Treatment For Peanut Allergy

The U.S. Food and Drug Administration has approved the first ever drug to treat peanut allergy, a life-threatening condition mainly for kids. Aimmune Therapeutics Inc.'s Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] can now be used to treat patients aged 4 through 17 years. The Palforzia drug reportedly will list for $890 a month.

from RTT - Biotech https://ift.tt/31n0NjH
via IFTTT
Read More »

Saturday, February 1, 2020

Healthcare IPOs For The Week Ahead

The IPO activity in the healthcare sector has had a strong start this year with 4 listings in January compared to only one last year during the month.

from RTT - Biotech https://ift.tt/2RQf3yz
via IFTTT
Read More »